Recently, a study investigating hypoxia-associated ICI resistance in NSCLC found that tumors with acquired ICI resistance frequently contained extensive hypoxic regions, which coincided with reduced infiltration of CD8+ T cells and downregulation of both MHC-I and MHC-II expression on tumor cells (75). Here, CD8A is linked to neoplasm.